GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Bharat Parenterals Ltd

Bharat Parenterals Ltd: Shareholders Approve Preferential Issue

FUNDRAISE ● No Immediate Change LOW RISK
📅 Filed on BSE: 25 Oct 2026, 02:37 PM IST  ·  BSE ID: ba1868a0-aa6e-400f-b7bb-3492bdef717f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company corrected a mistake in reporting how shareholders voted at a meeting, without changing the actual vote results.
🤖 AI Summary
  • Revised voting results submitted for EGM held October 23, 2026, following an error.
  • Correction involves reclassifying institutional shareholders previously listed incorrectly.
  • No change in votes cast, favour/against tallies, or resolution outcomes.
  • Shareholders approved issuance of equity shares on preferential basis and investments exceeding limits.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Total number of shareholders on record date
3757
Number of shareholders attended through Video Conferencing
28
🏢 How This Affects the Company
💰
Financial Impact
The preferential issue approved by shareholders will enable the company to raise capital, the specifics of which are subject to future disclosure.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders as this is a revised disclosure of voting results.
👤
Who Is Affected
All shareholders are informed of the corrected voting results from the October 23, 2026 EGM.
🔍
Management Signal
Management is committed to accurate reporting and compliance with SEBI LODR Regulations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Details of the preferential issue, including allotment and pricing.
Company's next quarterly results announcement.
Filings related to utilization of funds from preferential issue.
LOW RISK Filing addresses a clerical error in reporting, with no impact on the substance of resolutions passed.
💡 Investor Takeaway
Bharat Parenterals Ltd shareholders approved a preferential issue and investments exceeding limits. Revised voting results confirm no change in votes cast or resolution outcomes.
⚖️ Strengths & Concerns

✅ Positives

  • Shareholders approved the preferential issue of equity shares, a key capital raising initiative.
  • Board also received approval for investments exceeding specified limits, enabling strategic financial flexibility.
❓ Frequently Asked Questions
What was the purpose of the revised disclosure by Bharat Parenterals Ltd?
The company submitted revised voting results to correct an inadvertent error in classifying institutional shareholders during the EGM held on October 23, 2026.
Did the voting results change for Bharat Parenterals Ltd's EGM?
No, the revision only involved shareholder classification; there was no change in the votes cast or the outcome of any resolutions.
What key resolutions were approved by Bharat Parenterals Ltd shareholders?
Shareholders approved the issuance of equity shares on a preferential basis and investments exceeding limits specified under Section 186(2) of the Companies Act, 2013.
How many shareholders attended Bharat Parenterals Ltd's EGM via video conferencing?
A total of 28 shareholders attended the EGM through video conferencing, with 5 from the Promoter and Promoter Group and 23 from the Public category.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.